Identification of Q-markers for Schisandrae Sphenantherae Fructus in treating drug-induced liver injury based on network pharmacology, fingerprint and quantitative analysis.
10.19540/j.cnki.cjcmm.20230627.201
- Author:
Lu-Jie LIN
1
;
Ming-Xiao ZHANG
1
;
Hua LI
1
;
Xue-Mei LAN
2
;
Xiao-Lu WEI
1
;
Cong GUO
1
;
Bin YANG
1
Author Information
1. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
2. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China Southwestern University Chongqing 400715, China.
- Publication Type:Journal Article
- Keywords:
Schisandrae Sphenantherae Fructus;
drug-induced liver injury;
fingerprint;
network pharmacology;
quality markers
- MeSH:
Schisandra/chemistry*;
Network Pharmacology;
Drugs, Chinese Herbal/chemistry*;
Chemical and Drug Induced Liver Injury/drug therapy*
- From:
China Journal of Chinese Materia Medica
2023;48(20):5460-5473
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to establish the ultra-performance liquid chromatography(UPLC) fingerprint and multi-indicator quantitative analysis method for Schisandrae Sphenantherae Fructus(SSF) and to screen out the potential quality markers(Q-markers) of hepatoprotection based on network pharmacology. The similarity analysis was performed using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System, which showed that the similarity of the fingerprints of 15 samples from different regions ranged from 0.981 to 0.998. Eighteen common components were identified, from which 3 differential components were selected by cluster analysis and principal component analysis. The "component-target-pathway" network was built to predict the core components related to the hepatoprotective effects. Fourteen core components were screened by network pharmacology. They acted on the targets such as AKT1, CCND1, CYP1A1, CYP3A4, MAPK1, MAPK3, NOS2, NQO1, and PTGS2 to regulate the signaling pathways of lipid metabolism and atherosclerosis, hepatitis B, interleukin-17, and tumor necrosis factor. Considering the chemical measurability, characteristics, and validity, schisantherin A, anwulignan, and schisandrin A were identified as the Q-markers. The content of schisantherin A, anwulignan, and schisandrin A in the test samples were 0.20%-0.57%, 0.13%-0.33%, and 0.42%-0.70%, respectively. Combining the fingerprint, network pharmacology, and content determination, this study predicted that schisantherin A, anwulignan, and schisandrin A were the Q-markers for the hepatoprotective effect of SSF. The results can provide reference for improving the quality evaluation standard and exploring the hepatoprotective mechanism of SSF.
